Vaccination with a co‐expression DNA plasmid containing GAD65 fragment gene and IL‐10 gene induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes
暂无分享,去创建一个
Zhiguang Zhou | P. Zheng | Xia Li | Xinyuan Liu | Song Zhang | Fang Hu
[1] C. Mathieu,et al. Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis Reverses Diabetes in Recent-Onset NOD Mice , 2014, Diabetes.
[2] M. V. von Herrath,et al. Combination Therapy With an Anti–IL-1β Antibody and GAD65 DNA Vaccine Can Reverse Recent-Onset Diabetes in the RIP-GP Mouse Model , 2014, Diabetes.
[3] M. V. von Herrath,et al. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes. , 2013, Journal of autoimmunity.
[4] C. Mathieu,et al. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. , 2012, The Journal of clinical investigation.
[5] Juan Pedro López,et al. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. , 2012, The New England journal of medicine.
[6] M. Soares,et al. An Evaluation of the Spontaneous Proliferation of Peripheral Blood Mononuclear Cells in HTLV-1-Infected Individuals Using Flow Cytometry , 2011, ISRN oncology.
[7] Darrell M. Wilson,et al. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial , 2011, The Lancet.
[8] M. Battaglia,et al. Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes. , 2011, Seminars in immunology.
[9] M. V. von Herrath,et al. Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] Gisen Kim,et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.
[11] Jonathan H. Esensten,et al. T-bet-Deficient NOD Mice Are Protected from Diabetes Due to Defects in Both T Cell and Innate Immune System Function1 , 2009, The Journal of Immunology.
[12] Johnny Ludvigsson,et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. , 2008, The New England journal of medicine.
[13] Yan Li,et al. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles. , 2008, Immunology letters.
[14] J. Bluestone,et al. Constitutive Expression of B7-1 on B Cells Uncovers Autoimmunity toward the B Cell Compartment in the Nonobese Diabetic Mouse1 , 2007, The Journal of Immunology.
[15] Michael Loran Dustin,et al. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo , 2006, The Journal of experimental medicine.
[16] P. Snow,et al. Induction of Autoantigen-Specific Th2 and Tr1 Regulatory T Cells and Modulation of Autoimmune Diabetes1 , 2003, The Journal of Immunology.
[17] H. Mcdevitt,et al. CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer , 2002, The Journal of experimental medicine.
[18] Ethan M. Shevach,et al. CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.
[19] R. Sherwin,et al. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase , 2002, Diabetologia.
[20] M. V. von Herrath,et al. Plasmid Vaccination with Insulin B Chain Prevents Autoimmune Diabetes in Nonobese Diabetic Mice1 , 2001, The Journal of Immunology.
[21] R. Tisch,et al. Plasmid DNAs Encoding Insulin and Glutamic Acid Decarboxylase 65 Have Distinct Effects on the Progression of Autoimmune Diabetes in Nonobese Diabetic Mice1 , 2001, The Journal of Immunology.
[22] H. Weiner,et al. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. , 2001, International immunology.
[23] N. Sarvetnick,et al. Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection. , 2001, Clinical immunology.
[24] M. Filippova,et al. Effects of plasmid DNA injection on cyclophosphamide-accelerated diabetes in NOD mice. , 2001, DNA and cell biology.
[25] R. Tisch,et al. Antigen-Specific Mediated Suppression of β Cell Autoimmunity by Plasmid DNA Vaccination1 , 2001, The Journal of Immunology.
[26] D. Hassett,et al. Immune Responses following Neonatal DNA Vaccination Are Long-Lived, Abundant, and Qualitatively Similar to Those Induced by Conventional Immunization , 2000, Journal of Virology.
[27] R. Sherwin,et al. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. , 1999, Science.
[28] R. Tisch,et al. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. , 1999, Journal of immunology.
[29] R. Sherwin,et al. Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in β Cells , 1999 .
[30] D. Weiner,et al. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. , 1998, Journal of immunology.
[31] H. Kolb,et al. Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats , 1998, Diabetologia.
[32] R. Tisch,et al. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. , 1998, Diabetes.
[33] M. Atkinson,et al. Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice. , 1998, Journal of autoimmunity.
[34] R. Steinman,et al. Antigen Presentation by Dendritic Cells after Immunization with DNA Encoding a Major Histocompatibility Complex Class II–restricted Viral Epitope , 1997, The Journal of experimental medicine.
[35] I. Cohen,et al. The Th1/Th2 dichotomy, hsp60 autoimmunity, and type I diabetes. , 1997, Clinical immunology and immunopathology.
[36] A. Jevnikar,et al. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance , 1997, Nature Medicine.
[37] P. Musto,et al. Vaccination against influenza in multiple myeloma. , 1997, British journal of haematology.
[38] A. Tobin,et al. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes–prone mice , 1996, Nature Medicine.
[39] L. Harrison,et al. Aerosol Insulin Induces Regulatory CD8 γδ T Cells That Prevent Murine Insulin-dependent Diabetes , 1996, The Journal of experimental medicine.
[40] M. Colston,et al. Vaccination against tuberculosis by DNA injection , 1996, Nature Medicine.
[41] I. Cohen,et al. Suppressive vaccination with DNA encoding a variable region gene of the T–cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity , 1996, Nature Medicine.
[42] J. D. de Vries,et al. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells , 1996, The Journal of experimental medicine.
[43] M. Atkinson,et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes , 1996, The Journal of experimental medicine.
[44] D. Wegmann,et al. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Pléau,et al. Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65). , 1995, Clinical immunology and immunopathology.
[46] A. Tobin,et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes , 1993, Nature.
[47] R. Tisch,et al. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice , 1993, Nature.
[48] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[49] G. Acsadi,et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. , 1992, Human molecular genetics.
[50] M. Atkinson,et al. 64 000 Mr autoantibodies as predictors of insulin-dependent diabetes , 1990, The Lancet.
[51] M. V. von Herrath,et al. Type 1 diabetes: etiology, immunology, and therapeutic strategies. , 2011, Physiological reviews.
[52] Pau Serra,et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice , 2006, Nature Immunology.
[53] Y. Glinka,et al. DNA Vaccination against Autoimmune Diseases , 2005 .
[54] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[55] H. Mcdevitt,et al. Identification of immunogenic epitopes of GAD 65 presented by A g7 in non-obese diabetic mice , 1997, Immunogenetics.
[56] S. Ben‐Sasson,et al. Identification of dying cells--in situ staining. , 1995, Methods in cell biology.